New Jersey regulation may dramatically decrease the medical hashish price ticket for sufferers

With the approval of a new invoice (Senate Act 3799), which cleared a New Jersey General Assembly committee earlier this month, New Jersey lawmakers are currently working to reduce the high cost of medical cannabis for patients enrolled in the state. Aid would include programs for children, the elderly and crime victims, such as: a Report from NJ.com.

“The cost of medical cannabis is just out of reach for some people,” said Senator Joe Vitale, who supported the bill, during a hearing at the time the bill was approved. “In most cases, this would be someone who would qualify for financial reasons or because of an injury suffered.”

Health insurance in New Jersey does not cover any costs for patients as medical cannabis is still illegal at the federal level. The state also has some of the highest medical cannabis costs in the US; an ounce costs an average of $ 350 to $ 500, and this is mainly due to a slow expansion program and low competition, leading to skyrocketing demand.

The bill would require the following funds to cover medical cannabis costs: Disaster Relief Fund for Children, Pharmaceutical Aid for Elderly and Disabled People (PAAD), Senior Gold Prescription Discount Program, and Victims of Crime Compensation Office (VCCO).

Any fund would offer assistance with the cost of cannabis medication, but not necessarily cover it in full. The PAAD and senior programs would only reimburse pharmacies for medical expenses if a patient pays an additional payment or has reached a maximum out of pocket. The bill would also make medical cannabis indemnifiable as expenses for crime victims.

After New Jersey residents voted to legalize recreational cannabis in November 2020, the state spent much of 2021 focusing on its ongoing plans for Regulation of the cannabis infrastructure within the state.

Rep. Herb Conaway (D-Burlington) sponsored the bill that would allow more help and access to medical cannabis for New Jersey patients, and said the programs associated with the bill will be state-administered so there will be no conflict with federal law would.

“These programs serve those who are often at least financially distressed,” Conaway said during the committee hearing. “The goal is to ensure that the benefits of medical cannabis are available to all who may need it.”

Comments are closed.